BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aierken A, Xie YK, Dong W, Apaer A, Lin JJ, Zhao Z, Yang S, Xu ZZ, Yang F. Rational Design of a Modality-Specific Inhibitor of TRPM8 Channel against Oxaliplatin-Induced Cold Allodynia. Adv Sci (Weinh) 2021;8:e2101717. [PMID: 34658162 DOI: 10.1002/advs.202101717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Z, Deng Z, Wang Q, Wang Y, Zhang D, Xu R, Guo L, Wen H. Simulation and Machine Learning Methods for Ion-Channel Structure Determination, Mechanistic Studies and Drug Design. Front Pharmacol 2022;13:939555. [DOI: 10.3389/fphar.2022.939555] [Reference Citation Analysis]
2 Iraci N, Ostacolo C, Medina-peris A, Ciaglia T, Novoselov AM, Altieri A, Cabañero D, Fernandez-carvajal A, Campiglia P, Gomez-monterrey I, Bertamino A, Kurkin AV. In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical Screening. IJMS 2022;23:2070. [DOI: 10.3390/ijms23042070] [Reference Citation Analysis]